Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/03/1991 | WO1991014701A1 Improved major histocompatibility complex (mhc) molecules |
10/03/1991 | WO1991014695A1 Insect retinoid receptor compositions and methods |
10/03/1991 | WO1991014451A1 Bcrf1 antagonists for treating epstein-barr virus infections |
10/03/1991 | WO1991014449A1 Induction of protection against viral infection |
10/03/1991 | WO1991014448A1 New proteins, peptides and corresponding dna or rna sequences and probes useful for diagnosing tuberculosis |
10/03/1991 | WO1991014446A1 Crf analogs |
10/03/1991 | WO1991014438A1 Chimeric antibodies with receptor binding ligands in place of their constant region |
10/03/1991 | WO1991014369A1 Use of a coleopteran active bacillus thuringiensis for controlling the cereal leaf beetle oulema melanopa l. (lema melanopa (l.)) |
10/03/1991 | WO1991012273A3 Methods of producing hybrid g protein-coupled receptors |
10/03/1991 | WO1991011462A3 Merosin, nucleic acids encoding, fragments and uses thereof |
10/03/1991 | WO1991010910A3 Process for enzymatically treating substrates |
10/03/1991 | WO1991010735A3 Human receptor of tsh. sequence coding for such receptor |
10/03/1991 | CA2078131A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
10/03/1991 | CA2075192A1 Insect retinoid receptor compositions and methods |
10/03/1991 | CA2057040A1 Induction of protection against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein |
10/03/1991 | CA2039458A1 Methods for treating interleukin-1 mediated diseases |
10/02/1991 | EP0449770A2 Bacterial vectors |
10/02/1991 | EP0449769A1 CD 25 binding molecules |
10/02/1991 | EP0449170A1 Cellular binding protein with affinity for human type 18 papilloma virus regulatory region |
10/02/1991 | EP0449116A1 DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof |
10/02/1991 | EP0449079A2 Hydantoin derivative |
10/02/1991 | EP0448770A1 Method for separating collagen |
10/02/1991 | EP0448704A1 Osteogenic devices |
10/02/1991 | EP0448605A1 Use of basic amino acids to solubilize immunoglobulins |
10/02/1991 | EP0409892A4 Combining mutations for stabilization of subtilisin |
10/02/1991 | EP0228458B1 Epithelial cells expressing foreign genetic material |
10/02/1991 | EP0217804B1 Analogs of substances p |
10/02/1991 | CN1055010A Secretion of hirudin derivatives |
10/02/1991 | CN1055009A Production of human basic fgf-mutein |
10/02/1991 | CN1054900A Compositions and methods for treating infections caused by organisms sensitive to beta-lactam antibiotics |
10/01/1991 | WO1991015223A1 Respiratory burst suppression factor |
10/01/1991 | WO1991015111A1 A binary genetic system to control expression of a transgene in a transgenic animal |
10/01/1991 | US5053492 Reacting with epitope present in venom to form hydrophobic antigen/antibody complex; antitumor agent, antivenom agent |
10/01/1991 | US5053489 Carbohydrate-free; diagnostic immunoassay |
10/01/1991 | US5053488 Gene expression of human hormones |
10/01/1991 | US5053453 Protein covalently bound to support material |
10/01/1991 | US5053389 Insulin preparation for non-parenteral administration |
10/01/1991 | US5053386 Abrin and abrus agglutinin |
10/01/1991 | US5053337 Vectors, viruses, bacteriophage, plasmids, cells |
10/01/1991 | US5053331 Self-incompatibility gene |
10/01/1991 | US5053326 Hybridization method and probe |
10/01/1991 | CA2077686A1 Binary genetic system to control expression of a transgene in a transgenic animal |
10/01/1991 | CA2055593A1 Respiratory burst suppression factor |
10/01/1991 | CA2039481A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
10/01/1991 | CA2039359A1 Cellular binding protein having affinity for the regulatory region of the human papilloma virus type 18 |
10/01/1991 | CA2027447A1 Glycosaminoglycan-modified protein |
10/01/1991 | CA1290097C Peptide enzyme inhibitors |
10/01/1991 | CA1289880C Anti-human ovarian cancer immunotoxins and methods of use thereof |
10/01/1991 | CA1289878C Composition for stimulating chondrocytes and osteoblasts (osseinhydroxyapatite compound), method for its production and pharmaceutical products containing said composition |
09/30/1991 | WO1991014703A1 Hepatitis b vaccine |
09/30/1991 | EP0458908A4 Animal model for benign prostatic disease. |
09/25/1991 | EP0448513A2 Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof |
09/25/1991 | EP0448511A1 Anti-pathogenically effective compositions comprising lytic peptides and hydrolytic enzymes |
09/25/1991 | EP0448464A1 Method for determining the capacity of a spermatozoid to undergo the acrosomal reaction |
09/25/1991 | EP0448355A2 Antibiotic agents |
09/25/1991 | EP0448301A2 Antibiotic agents |
09/25/1991 | EP0448181A2 Interleukin-6 inhibiting compositions |
09/25/1991 | EP0448126A1 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
09/25/1991 | EP0448099A2 Novel peptides |
09/25/1991 | EP0448095A1 Subregion of the retroviral ENV protein, DNA sequences encoding it and compositions for the diagnosis, prevention or therapy of retrovirus infections |
09/25/1991 | EP0448093A2 Secretion of hirudin derivatives |
09/25/1991 | EP0448075A1 Immunoglobulin G and process for the production thereof |
09/25/1991 | EP0447956A1 Plasmodium sporozoite antigen |
09/25/1991 | EP0447836A2 Amyloid peptide precursor RNA |
09/25/1991 | EP0447808A2 Expression of Plasmodium falciparum polypeptides from cloned cDNA |
09/25/1991 | EP0447523A1 Compositions and methods for treating or preventing infections in canine and feline animals |
09/25/1991 | EP0447493A1 New strain of bacillus thuringiensis |
09/25/1991 | EP0447476A1 New tnf peptides |
09/25/1991 | EP0447474A1 New tnf peptides |
09/25/1991 | EP0447472A1 New tnf peptides |
09/25/1991 | EP0447465A1 New tnf peptides |
09/25/1991 | EP0447435A1 Novel tnf peptides |
09/25/1991 | EP0447432A1 New tnf peptides |
09/25/1991 | EP0447431A1 New tnf peptides |
09/25/1991 | EP0447430A1 New tnf peptides |
09/25/1991 | EP0447429A1 New tnf peptides |
09/25/1991 | EP0447424A1 Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
09/25/1991 | EP0420964A4 Lyophilized peptide formulations |
09/25/1991 | EP0378671A4 Insulinomimetic and insulin receptor binding site peptides |
09/25/1991 | EP0344302A4 Regeneration and transformation of cotton |
09/25/1991 | CN1054799A Polypeptides relating biology synthetic cobalamins and/or cobamides, coding dna sequence of polypeptides, process for preparing them and use |
09/25/1991 | CN1054773A Hemoregulatory peptides |
09/25/1991 | CN1054772A Synthetic polypeptides |
09/24/1991 | USRE33699 Polypeptides having norleucine, asparagine and aspartic acid groups to stimulate the release of Growth Hormone |
09/24/1991 | US5051526 Reagents for solid phase synthesis of polypeptides |
09/24/1991 | US5051496 Polypeptides encoded by DNA fragments for detection of AIDS |
09/24/1991 | US5051403 Method of treating ischemia-related neuronal damage |
09/24/1991 | US5051401 Inhibition of mineral deposition by phosphorylated and related polyanionic peptides |
09/24/1991 | US5051371 Polypeptides with cystine groups for diagnosis of cancer and the immune systems |
09/24/1991 | US5051355 Anti-human gastric cancer monoclonal antibody |
09/24/1991 | US5051254 Immunoprophylactic polypeptides for schistosomiasis |
09/24/1991 | CA2038911A1 Catalytic antibody components |
09/24/1991 | CA2038533A1 Protein phosphatase inhibitor-1 gene and expression |
09/24/1991 | CA2037151A1 Plasmodium sporozoite antigen |
09/24/1991 | CA1289474C Antibodies useable as pilot agents, and compounds containing same |
09/23/1991 | CA2038706A1 Bacterial vectors |
09/22/1991 | WO1991014436A1 Reagents and methods for modulating gene expression through rna mimicry |
09/22/1991 | CA2078659A1 Reagents and methods for modulating gene expression through rna mimicry |
09/22/1991 | CA2038569A1 Process for production of peptidylglycine ó-hydroxylating monooxygenase and use thereof |
09/21/1991 | CA2038581A1 Seroreactive epitopes of human papillomavirus (hpv) 16 proteins |